What AI says about Guardant Health
Guardant Health is a precision oncology company that provides blood-based tests to reveal tumor DNA for cancer screening, treatment guidance, and monitoring.
Since Jul 5Updated Nov 10, 2026Based on 22,056 AI answers
Reviewed by Dimitry Apollonsky
Mentioned in · Public index
<1%
of AI answers about Guardant Health and its rivals · since Jul 5
Based on 22,056 AI answers
- ChatGPT<1%
- Google AI Mode<1%
How often AI mentions Guardant Health
of AI answers about Guardant Health and its rivals
Track your brand free to see 13 weeks of history.
Use the left and right arrow keys to read each date.
Sep 14OctNov 2
- · ChatGPT switched to GPT-6 Luna
Questions and answers
- AI picks mostMentioned in
- Which startups help doctors use patient-specific diagnostics to choose treatments earlier?on this questionAI picks Tempus most32%
Excerpts where Guardant Health appeared in the AI's answer
ChatGPTSep 17, 2026, ChatGPT Guardant Health — Uses blood-based circulating-tumor-DNA testing to identify actionable mutations.
Google AI ModeSep 9, 2026, Google AI Mode Guardant Health provides blood- and tissue-based genomic profiling (such as Guardant Complete) that looks at circulating tumor DNA to detect residual disease, recurrences, and actionable biomarkers early in treatment planning.
- Which diagnostic AI tools are strongest for early detection using imaging, blood tests, or wearable signals?on this questionAI picks Aidoc and 2 more about as often38%
Excerpts where Guardant Health appeared in the AI's answer
ChatGPTSep 19, 2026, ChatGPT Guardant Health — develops blood-based genomic tests, especially in oncology.
Google AI ModeSep 19, 2026, Google AI Mode Shield (Guardant Health): An FDA-approved blood test for colorectal cancer screening
- As a 45-year-old with a family history of cancer, which early-detection blood test should I consider?on this questionAI picks Galleri most5%
- What's the best multi-cancer early-detection blood test available now?on this questionAI picks Galleri most7%
Excerpts where Guardant Health appeared in the AI's answer
Google AI ModeSep 5, 2026, Google AI Mode Guardant Health (Shield and Pipeline): While Guardant’s Shield test is commercially available specifically for colorectal cancer screening
- We need AI to identify disease risk from longitudinal patient data. What products should we consider?on this questionAI picks Tempus and 1 more about as often2%
Excerpts where Guardant Health appeared in the AI's answer
ChatGPTSep 1, 2026, ChatGPT Guardant Health InfinityAI - Best for: oncology-focused predictive analytics.
- I want to combine genome data, lab results, wearables, and medical history into personalized health recommendations. What AI tools exist?on this questionAI picks InsideTracker and 9 more about as often2%
Excerpts where Guardant Health appeared in the AI's answer
Google AI ModeJul 29, 2026, Google AI Mode Guardant Health: Specializes in using AI for liquid biopsy and genomic testing to guide cancer therapy decisions.
Guardant Health in AI answers
1 of 5
Which diagnostic AI tools are strongest for early detection using imaging, blood tests, or wearable signals?
ChatGPTChatGPT· Sep 19, 2026
Guardant Health — develops blood-based genomic tests, especially in oncology.
Google AI ModeGoogle AI Mode· Sep 19, 2026
Shield (Guardant Health): An FDA-approved blood test for colorectal cancer screening
Sites AI cites
- Your site20%
- Guardant Health | Conquering Cancer With Data (opens in a new tab) · 9%
- Early-Stage Cancer Studies | Guardant Health (opens in a new tab) · 3%
- Our Approach | Guardant Health (opens in a new tab) · 3%
- Guardant Health (opens in a new tab) · 3%
- Guardant Complete® for Early and Advanced Stage Cancer | Guardant Health (opens in a new tab) · 3%
- Your site9%
- Guardant Health Announces FDA Approval of Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheim’s HERNEXEOS® | Guardant Health Investor Relations (opens in a new tab) · 6%
- Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform | Guardant Health Investor Relations (opens in a new tab) · 3%
